Key points are not available for this paper at this time.
Given the high toxicity of inorganic inhibitors, organic substances, primarily heterocycles, have been proven to be one of the most efficient, cost-effective, and practical alternatives.
Verma et al. (Mon,) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: